Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • Newsletter
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 4170
  • 4171
  • 4172
  • …
  • ›
  • »

2026-08-05

MasterBrand outlines $2.05B-$2.11B second-half 2026 sales while targeting net leverage below 2x by end of 2028

2026-08-05

CSPC PHARMA HB1801 Combined With ALPHAMAB-B KN026 Neoadjuvant Therapy NDA Accepted

2026-08-05

Galan Lithium Limited: Galan Lithium Releases Updated Investor Presentation

2026-08-05

Takeda aims for dengue vaccine inclusion in India′s shots program

2026-08-05

CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results

2026-08-05

AIxCrypto Announces Second Quarter 2026 Earnings Conference Call Details

2026-08-05

Teradata signals $330M-$350M adjusted free cash flow range while launching Teradata 3.0 agentic platform

2026-08-05

Pacira outlines $735M-$760M 2026 revenue guidance while targeting 160M EXPAREL covered lives

2026-08-05

US Mulls Setting Floor Prices and Additional Tariffs on Polysilicon Imports: Wire

2026-08-05

Utah Backs Anson Resources′ Green River Lithium Development with Proposed US$357.7m Incentive

2026-08-05

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

2026-08-05

Gilead outlines 2026 base business sales of $29.8B-$30.1B while raising HIV growth outlook to 9%-10%

  • «
  • ‹
  • …
  • 4170
  • 4171
  • 4172
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 22/Sep/2026 13:48:02
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies